- Home
- CANF vs MXC Comparison
CANF vs MXC Comparison
Compare CANF & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- MXC
- Stock Information
- Founded
- CANF 1994
- MXC 1972
- Country
- CANF Israel
- MXC United States
- Employees
- CANF N/A
- MXC N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- MXC Oil & Gas Production
- Sector
- CANF Health Care
- MXC Energy
- Exchange
- CANF Nasdaq
- MXC Nasdaq
- Market Cap
- CANF 14.8M
- MXC 13.3M
- IPO Year
- CANF N/A
- MXC N/A
- Fundamental
- Price
- CANF $1.10
- MXC $6.97
- Analyst Decision
- CANF Strong Buy
- MXC
- Analyst Count
- CANF 2
- MXC 0
- Target Price
- CANF $14.00
- MXC N/A
- AVG Volume (30 Days)
- CANF 68.3K
- MXC 1.7K
- Earning Date
- CANF 06-17-2025
- MXC 06-26-2025
- Dividend Yield
- CANF N/A
- MXC 1.41%
- EPS Growth
- CANF N/A
- MXC N/A
- EPS
- CANF N/A
- MXC 0.63
- Revenue
- CANF $674,000.00
- MXC $7,161,739.00
- Revenue This Year
- CANF $461.72
- MXC N/A
- Revenue Next Year
- CANF N/A
- MXC N/A
- P/E Ratio
- CANF N/A
- MXC $10.73
- Revenue Growth
- CANF N/A
- MXC 2.12
- 52 Week Low
- CANF $0.98
- MXC $5.89
- 52 Week High
- CANF $4.69
- MXC $14.11
- Technical
- Relative Strength Index (RSI)
- CANF 46.91
- MXC 51.73
- Support Level
- CANF $1.07
- MXC $6.79
- Resistance Level
- CANF $1.12
- MXC $6.99
- Average True Range (ATR)
- CANF 0.03
- MXC 0.18
- MACD
- CANF 0.02
- MXC 0.03
- Stochastic Oscillator
- CANF 75.00
- MXC 43.14
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About MXC Mexco Energy Corporation
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.